Navigation Links
Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable
Date:11/6/2009

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- The U.S. bishops sent an urgent message to the U.S. House of Representatives November 6, as House members steeped themselves in debate over procedures related to abortion and the health care reform bill.

Moments before meeting to discuss proposed amendments to the bill, the bishops called for "a fair process" that would permit discussion of "an amendment to keep in place current federal law on abortion funding and conscience protections." Some in the House seek a "closed rule," a procedure banning amendments from the bill.

The letter was signed by Bishop William Murphy of Rockville Centre, New York, Chairman of the bishops' Domestic Justice Committee, Cardinal Justin Rigali, chair of the Committee on pro-life Activities, and Bishop John Wester of Salt Lake City, chair of the Committee on Migration. The letter follows.

Dear Representative:

On behalf of the United States Conference of Catholic Bishops (USCCB), we write to strongly urge you to vote for essential changes and a fair process in the House of Representatives to ensure that needed health care reform legislation truly protects the life, dignity, health and consciences of all. Unfortunately, the legislation moving to the House floor falls fundamentally short of this essential goal. We urge members of the House to:

  • support an amendment to keep in place the current federal law on abortion funding and conscience protections and to oppose a closed rule that would prevent the House from voting on this crucial matter;
  • oppose measures that would leave immigrants, especially legal immigrants, worse off as a result of health reform;
  • support access for immigrants to the health-insurance exchange, regardless of legal status, and support removal of the five-year ban on legal immigrants accessing Medicaid and other federal health-care programs; and
  • support strong provi
    '/>"/>

SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Connecticut Bishops Back Down over Provision of Emergency Contraception
2. U.S. Catholic Bishops Pro-Life Secretariat to Congress: Support the Mexico City Policy
3. Bishops Conference Praises Senate Introduction of Pregnant Women Support Act
4. Catholics Reject Influence of US Bishops in Congressional HIV/AIDS Funding Battle
5. Catholic Bishops Welcome New Bill for Global HIV/AIDS Relief
6. Catholic Bishops Official Available for Interview/Comment During Popes U.S. Visit
7. Lutheran, Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan
8. Coalition Asks Bishops to Take Politicians to Task
9. Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research
10. American Life League: Vatican Says Bishops Must Refuse Communion to Pro-Abortion Politicians
11. Bishops Pro-Life Official Gravely Concerned Over Threat to HHS Conscience Protection Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 Plugin creators ... TransFold Volume 2. A fully customizable transition ... “TransFold Volume 2 gives users total control over 30 ... Austin, CEO of Pixel Film Studios. “TransFold Volume 2 ... editor.” , TransFold Volume 2 from Pixel Film Studios ...
(Date:2/28/2015)... California (PRWEB) February 28, 2015 ... supported and showcased emerging brand at Houston Texas ... in Las Vegas sending its executive delegates headed ... of Business Development and Training Randolph Clarito. , ... (IFA), was held last February 4-7 and featured ...
(Date:2/27/2015)... A new study published in the Journal ... cycle on a regular basis and prostate cancer. While cycling ... the more hours per week a man spends cycling, the ... an increased importance on prostate cancer screening methods. , “This ... closely at patents’ risk factors for developing prostate cancer,” says ...
(Date:2/27/2015)... 2015 On March 2-4, the ... National Cancer Institute (NCI) will co-host the annual ... Institutes of Health (NIH), in Bethesda, Maryland. The ... to medical professionals and scientists who specialize in ... general public, including patients, their families, and caregivers. ...
(Date:2/27/2015)... February 27, 2015 Pipette.com announces their ... , price is only valid until the end of ... looking for a vortex mixer that allows for absolute ... founded in 1954 and is headquartered in Bohemia, New ... shakers, as well as other rockers, incubators, and hybridization ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2
... has joined Element,Six as head of E6 Ventures ... venture,business to identify and invest in new business ... Element Six has made significant,funds available to support ... an important enabling technology. The aim is to,provide ...
... - Online Resource to Support Journal Editors ... publisher of scientific, technical and,medical information products ... Publishing Ethics Resource Kit (PERK),( http://www.elsevier.com/publishingethicskit )., ... Conference in Singapore, Mark,Seeley, Senior Vice President ...
... More Than 50 percent of Americans Vitamin D Deficient, Dr. ... - but for Only 10 Minutes Weekly; Wear,Sunscreen With UVA ... CHARLESTON, S.C., March 4 As many as half of ... evidence shows a link,between low vitamin D levels and cancer, ...
... 4 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ... generic,pharmaceuticals and manufacturer of the patented anti-cancer biotech,product ... is a gold medal,winner of the 10th Outstanding ... Property Office of the People,s Republic of China,(SIPO)., ...
... of chronic obstructive pulmonary disease (COPD) should not be,screened ... from the U.S. Preventive Services Task Force. The,recommendation and ... Annals of Internal Medicine. It will appear in the ... is a lung disease in which the airways in ...
... of human embryonic stem cells (hESCs) also inhibits the ... cancer, Northwestern University researchers have discovered. Metastatic melanoma, which ... melanocytes, has a death rate of more than 80 ... months. , The Northwestern scientists, led by researcher ...
Cached Medicine News:Health News:Element Six Signals Ambitions for Growth With Senior Appointment for New Ventures Unit 2Health News:Elsevier Launches Publishing Ethics Resource Kit 2Health News:Renowned Doctor Says Best Way to Obtain Crucial Vitamin D Is From Sun; but Still, Don't Forget Sunscreen 2Health News:Renowned Doctor Says Best Way to Obtain Crucial Vitamin D Is From Sun; but Still, Don't Forget Sunscreen 3Health News:Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 3Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3
(Date:2/27/2015)... OF PRUSSIA, Pa. , Feb. 27, 2015 /PRNewswire/ ... of its ongoing commitment to the global bleeding disorders ... is donating 2 million international units (IUs) of protein ... is an international not-for- profit organization which has worked ... other inherited bleeding disorders. The donation supports the WFH,s ...
(Date:2/27/2015)... N.J., Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... and reported financial results for the fourth quarter and ... "2014 was a transformative year for PTC. We are ... and developing RNA-targeted therapies in the rare disease space," ... Therapeutics, Inc. "We are proud to bring the first ...
(Date:2/27/2015)... 2015 ... kongestive Herzinsuffizienz (CHF) in seiner ersten klinischen ...   Die israelische Firma ... für Patienten mit kongestiver Herzinsuffizienz (CHF) entwickelt ... Finanzierungsvorhaben über 5 Mio. USD abgeschlossen hat. ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... and preventive vaccines against cancers and infectious diseases, announced ... journal Human Vaccines detailing potent immune responses ... for prostate cancer targeting two antigens. While current prostate ...
... (NYSE: BSX ) today announced financial results for the ... as net sales and earnings per share (EPS) guidance for the ... highlights: Reported sales of $2.002 billion with ... diluted share of $0.20. Increased year-over-year International ICD ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 2Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 3Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 4Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 5Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 6Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 7Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 8Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 9Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 10Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 11Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 12Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 13Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 14Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 15Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 16Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 17Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 18Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 19Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 20Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 21Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 22
... Inteq TFCC small joint ... of the triangular fibrocartilage ... capsule when peripheral separation ... system should be used ...
Low-profile hand-held instruments....
... The Mini Bio-Anchor with ... x 7 mm bioabsorbable implant ... pull-out strength. The bioabsorbable, PLDLA ... fixation strength throughout the tissue ...
... Fusion Screw is a headless ... of variable thread pitch and ... holding power. The Acutrak Fusion ... of the IP and DIP ...
Medicine Products: